A Canadian Market Focus
Verde Science’s focus is the Canadian markets, where medical marijuana is legal if patients have a doctor’s prescription. As a new entrant into the Canadian market, Verde Science will bring much more than economy of scale, with it’s new, technology-driven approach that could be a game changer. Most of Canada, lacks strong corporate players in the research and product development (including aeroponic technology) of medical marijuana remedies.
Medical Marijuana Regulation in Canada
The regulation on access to cannabis for medical purposes, established by Health Canada in July 2001, defines two categories of patients eligible for access to medical cannabis. BC College of Physicians and Surgeons’ recommendation, as well as the CMPA position, is that physicians may prescribe cannabis if they feel comfortable doing. The MMAR forms are a confidential document between Health Canada, the physician and the patient. The information is not shared with the College or with the RCMP. No doctor has ever gone to court or faced prosecution for filling out a form or for prescribing medical cannabis.
Category 1
Covers any symptoms treated within the context of providing compassionate end-of-life care or at least one of the symptoms associated with the following medical conditions:
- Severe pain and/or persistent muscle spasms from multiple sclerosis, from a spinal cord injury, from spinal cord disease
- Severe pain, cachexia, anorexia, weight loss, and/or severe nausea from cancer or HIV/AIDS infection
- Severe pain from severe forms of arthritis
- Seizures from epilepsy